NCT03886714Terminated
Screening for Fabry Disease in Renal Transplantation
Source: ClinicalTrials.gov · Last updated 16 May 2025
Reason given: Low recreuitement numbers and end of grant.
Brief summary (registry, in English)
Single centre, prospective pilot study examining the relevance to screen for Fabry disease in a cohort of patients who have undergone renal transplantation for nephropathy of indeterminate cause, vascular nephropathy, diabetic nephropathy or secondary focal segmental hyalinosis with no established cause.
- Status (registry)
- Terminated
- Study type
- Observational
- Enrollment
- 592 (actual)
- First submitted
- 20 Mar 2019
- Start date
- 25 Mar 2019
- Primary completion date
- 31 Dec 2024
- Lead sponsor
- University Hospital, Montpellier
- Diseases
- Fabry disease, Chronic kidney disease
- NCT number
- NCT03886714
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- N/A
Who the study is looking for
- Nephropathy of indeterminate cause, or secondary FSH or diabetic nephropathy
- Patients with kidney transplanted
- Patients still followed at the Montpellier University Hospital
- Obtaining written informed consent
- Age > 18 years old, no upper age limit
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Uh Montpellier | Montpellier | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.